Atlas Trials

Dose-finding Study of ASP2151 in Subjects With Herpes Zoster

Clinical trial NCT00487682 · COMPLETED

Trial details

NCT number
NCT00487682
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2007-11-13
Primary completion
2008-09-01
Enrollment
403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.